Drug retention and safety of TNF inhibitors in elderly patients with rheumatoid arthritis

被引：0
|
作者：
Soo-Kyung Cho
Yoon-Kyoung Sung
Dam Kim
Soyoung Won
Chan-Bum Choi
Tae-Hwan Kim
Jae-Bum Jun
Dae-Hyun Yoo
Sang-Cheol Bae
机构：
[1] Hanyang University Hospital for Rheumatic Diseases,Department of Rheumatology
[2] Clinical Research Center for Rheumatoid Arthritis,undefined
来源：
BMC Musculoskeletal Disorders | / 17卷
关键词：
Rheumatoid arthritis; TNF inhibitor; Elderly; Safety; Drug retention rate;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Comparison of drug retention rates and causes of drug discontinuation between anti-TNF agents in rheumatoid arthritis patients
    Du Pan, S. M. C. Martin
    Dehler, S.
    Gabay, C.
    Finckh, A.
    SWISS MEDICAL WEEKLY, 2007, 137 : 3S - 3S
  • [22] Comparison of drug retention rates and causes of drug discontinuation between anti-TNF agents in rheumatoid arthritis patients
    Du Pan, S. M. C. Martin
    Dehler, S.
    Gabay, C.
    Finckh, A.
    Scqm-Ra, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 181 - 181
  • [23] Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
    Pers, Yves-Marie
    Schaub, Roxane
    Constant, Elodie
    Lambert, Joseph
    Godfrin-Valnet, Marie
    Fortunet, Clementine
    Bourichi, Waafa
    Prades, Beatrice Pallot
    Wendling, Daniel
    Gaudin, Philippe
    Jorgensen, Christian
    Maillefert, Jean-Francis
    Marotte, Hubert
    JOINT BONE SPINE, 2015, 82 (01) : 25 - 30
  • [24] SAFETY OF BIOLOGIC AGENTS IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Murota, A.
    Kaneko, Y.
    Yamaoka, K.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 480 - 480
  • [25] Safety of Biologic Agents in Elderly Patients with Rheumatoid Arthritis
    Murota, Atsuko
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Takeuchi, Tsutomu
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) : 1984 - 1988
  • [26] EFFICACY AND SAFETY OF TOCILIZUMAB IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
    Pers, Y. -M.
    Schaub, R.
    Fortunet, C.
    Constant, E.
    Lambert, J.
    Godfrin-Valnet, M.
    Pallot-Prades, B.
    Wendling, D.
    Gaudin, P.
    Marotte, H.
    Maillefert, J. -F.
    Jorgensen, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 689 - 689
  • [27] Recommendations for drug therapy of rheumatoid arthritis in elderly patients
    Nesher, G
    Moore, TL
    CLINICAL IMMUNOTHERAPEUTICS, 1996, 5 (05): : 341 - 350
  • [28] Safety of tnf inhibitors and non-biologic DMARDs in rheumatoid arthritis patients previously treated with rituximab
    Emery, Paul
    Genovese, Mark C.
    Breedveld, Ferdinand
    Moreland, Larry
    Keystone, Edward
    Matteson, Eric L.
    Baptiste, Y.
    Reiss, William
    Sweetser, Marianne
    Shaw, Tim
    RHEUMATOLOGY, 2008, 47 : II48 - II49
  • [29] Discontinuation of TNFα inhibitors in rheumatoid arthritis and psoriatic arthritis
    Oskarsdottir, Thorunn
    Gunnarsdottir, Anna Ingibjorg
    Gudbjornsson, Bjorn
    Gunnarsson, Petur Sigurdur
    Love, Thorvardur
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 182 - 183
  • [30] Influence of Rheumatoid Factor on Serum Drug Levels of TNF Inhibitors with Different Structures in Rheumatoid Arthritis
    Martinez Feito, Ana
    Plasencia-Rodriguez, Chamaida
    Novella-Navarro, Marta
    Gehin, Johanna E.
    Hernandez-Breijo, Borja
    Brenis, Claudia M.
    Villalba, Alejandro
    Fernandez-Fernandez, Elisa
    Monjo, Irene
    Pascual-Salcedo, Dora
    Nozal, Pilar
    Balsa, Alejandro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2580 - 2582
12345